Clinical Trial

Two-channel IV-PCA With Dexmedetomidine

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 3, 2025 (before its estimated October 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Dexmedetomidine was administered in the 'selector' channel and fentanyl in the 'basic \& bolus' channel of dual channel intravenous patient-controlled analgesia (IV-PCA) and the amount of opioid consumption was compared. In addition, intensity of pain, postoperative nausea/vomiting, and postoperative delirium was evaluated.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-01-03; most recent amendment 2025-01-02.
Status change: Not Yet Recruiting → Recruiting 2023-03-13
Trial Details
NCT Number NCT05672225
Lead Sponsor Korea University Guro Hospital
Conditions Analgesia, Patient-Controlled, Dexmedetomidine
Enrollment 110 participants
Start Date 2023-02-07
Primary Completion 2025-10-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-03